User Agreement

Section 1: Contractual Framework & Consent

This Agreement establishes a binding legal relationship between you and DramaView. By initiating the download or accessing our digital library, you signify your full acceptance of these terms. If these conditions are unacceptable to you, please terminate your use of the application immediately.

Section 2: Profile Management & Security Obligations

While basic browsing is available, certain premium features necessitate the creation of a verified user profile. You are the primary custodian of your login credentials and are responsible for all activities occurring under your account. Any suspected security breaches should be reported to contact@j2n7dv.com. You retain the right to terminate your account at your discretion.

Section 3: Intellectual Property & Viewing Licenses

DramaView provides a curated selection of short-form entertainment for private, non-commercial use. All software code, visual media, and soundtracks are the exclusive property of DramaView or its content partners. We grant you a limited, non-transferable license to view this content; however, any form of redistribution, copying, or unauthorized broadcasting is strictly forbidden.

Section 4: Monetization & Commercial Engagement

The standard version of DramaView is supported by targeted advertisements. Users may opt for a "Premium Experience" through paid subscriptions to remove these interruptions. All financial processing for these upgrades is managed securely through the official App Store or Google Play billing systems.

Section 5: Code of Conduct & Prohibited Actions

To maintain a healthy ecosystem, users are prohibited from: (a) attempting to bypass security layers; (b) deploying automated scripts or malware; (c) using the platform for unsolicited marketing; or (d) violating the copyrights of other creators.

Section 6: Liability Limitations & Jurisdiction

Any legal disputes arising from this agreement shall be governed by the laws of your local jurisdiction.

Effective: December 2025